Federal officials are planning to sharply increase production of ZMapp, which is viewed by many experts as the most promising experimental drug for treating people infected with Ebola in West Africa.
U.S. will increase production of the Ebola drug ZMapp, but may not meet demand
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.